Old Web
English
Sign In
Acemap
>
Paper
>
P2.09-03 Prognostic Value of Mutated KRAS in Circulating Tumor DNA Prior to Therapy in Patients with Lung Adenocarcinoma
P2.09-03 Prognostic Value of Mutated KRAS in Circulating Tumor DNA Prior to Therapy in Patients with Lung Adenocarcinoma
2019
Sissel Gyrid Freim Wahl
Hong Yan Dai
E.F. Emdal
A.L. Ottestad
Elin Richardsen
T.O. Halvorsen
Bjørn Henning Grønberg
Keywords:
Pathology
Adenocarcinoma
KRAS
Cancer research
Circulating tumor DNA
Lung
Medicine
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]